Effects of ADIPOQ and NOS3 SNPs/haplotypes on Blood Pressure Control in Patients With Adherence to Antihypertensive Therapy
Pharmacogenomics · 2023-04 · 24 (5) · 269-281
DOI: 10.2217/pgs-2023-0012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacogenomics, online erschienen am 04.04.2023. Verfasst von Warlley R Cunha und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Pharmacy, Federal University of Ouro Preto, CEP, 35400-000, Ouro Preto, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Antihypertensive Agents, Hypertension. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Municipal Health Department of Ouro Preto.
Abstract (Originalsprache)
Aim: We examined whether ADIPOQ (rs266729 and rs1501299) and NOS3 (rs3918226 and rs1799983) SNPs or the haplotypes formed by them, affect blood pressure (BP) control in 196 patients with adherence to antihypertensive therapy grouped into controlled (BP
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, School of Pharmacy, Federal University of Ouro Preto, CEP, 35400-000, Ouro Preto, Minas Gerais, Brazil.
- Department of Clinical Analysis, School of Pharmacy, Federal University of Ouro Preto, CEP, 35400-000, Ouro Preto, Minas Gerais, Brazil.
- Department of Genetics, Ecology & Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, CEP, 31270-901, Belo Horizonte, MG, Brazil.
- Division of Cardiology, Department of Medicine, Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, New York, NY, USA.
ORCID-Profile: Warlley R Cunha, Marcelo R Luizon, Vanessa A Belo
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Municipal Health Department of Ouro Preto
- Federal University of Ouro Preto
Zitieren
APA
Cunha, W. R., Agostini, L. C., Dos Moreira, W. M., M Teixeira, L. F., Vital, W. C., da Silva, G. N., Silva, N. N., Luizon, M. R., Oliveira-Paula, G. H., Lima, A. A., & Belo, V. A. (2023). Effects of ADIPOQ and NOS3 SNPs/haplotypes on Blood Pressure Control in Patients With Adherence to Antihypertensive Therapy. Pharmacogenomics, 24(5), 269-281. https://doi.org/10.2217/pgs-2023-0012
Vancouver
Cunha WR, Agostini LC, Dos Moreira WM, M Teixeira LF, Vital WC, da Silva GN, et al. Effects of ADIPOQ and NOS3 SNPs/haplotypes on Blood Pressure Control in Patients With Adherence to Antihypertensive Therapy. Pharmacogenomics. 2023;24(5):269-281. doi:10.2217/pgs-2023-0012
BibTeX
@article{Cunha2023,
author = {Cunha, Warlley R and Agostini, Lívia C and Dos Moreira, Wellington Ms and M Teixeira, Luiz Fernando and Vital, Wendel C and da Silva, Glenda N and Silva, Nayara Nt and Luizon, Marcelo R and Oliveira-Paula, Gustavo H and Lima, Angélica A and Belo, Vanessa A},
title = {Effects of ADIPOQ and NOS3 SNPs/haplotypes on Blood Pressure Control in Patients With Adherence to Antihypertensive Therapy},
journal = {Pharmacogenomics},
year = {2023},
volume = {24},
number = {5},
pages = {269--281},
doi = {10.2217/pgs-2023-0012}
}
EUVIMED